These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14979908)

  • 101. WNT signalling and haematopoiesis: a WNT-WNT situation.
    Staal FJ; Clevers HC
    Nat Rev Immunol; 2005 Jan; 5(1):21-30. PubMed ID: 15630426
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs.
    Gebeshuber CA; Sladecek S; Grunert S
    Cells Tissues Organs; 2007; 185(1-3):51-60. PubMed ID: 17587808
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Wnt signalling and the mechanistic basis of tumour development.
    Ilyas M
    J Pathol; 2005 Jan; 205(2):130-44. PubMed ID: 15641015
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Epidermal growth factor].
    Inobe M; Takeda S
    Tanpakushitsu Kakusan Koso; 2000 Sep; 45(13 Suppl):2116-22. PubMed ID: 11021212
    [No Abstract]   [Full Text] [Related]  

  • 105. ADAM metalloproteases and EGFR signalling.
    Gee JM; Knowlden JM
    Breast Cancer Res; 2003; 5(5):223-4. PubMed ID: 12927027
    [No Abstract]   [Full Text] [Related]  

  • 106. Growth factor signalling in endocrine and anti-growth factor resistant breast cancer.
    Nicholson RI; Hutcheson IR; Jones HE; Hiscox SE; Giles M; Taylor KM; Gee JM
    Rev Endocr Metab Disord; 2007 Sep; 8(3):241-53. PubMed ID: 17486454
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [Clinical significance of investigating epidermal growth factor receptors in breast cancer].
    Gershteĭn ES; Bassalyk LS; Letiagin VP
    Vopr Onkol; 1994; 40(7-12):266-75. PubMed ID: 7610619
    [No Abstract]   [Full Text] [Related]  

  • 108. Wnt signaling and orthopedic diseases.
    Ishikawa Y
    Am J Pathol; 2005 Jul; 167(1):1-3. PubMed ID: 15972946
    [No Abstract]   [Full Text] [Related]  

  • 109. Environmental causes and molecular biology of breast cancer: future research directions.
    Jahnke GD; Barrett JC
    Prog Clin Biol Res; 1996; 394():455-69. PubMed ID: 8778810
    [No Abstract]   [Full Text] [Related]  

  • 110. What's new in the importance of receptors in pathology?
    Dietel M; Kostrouch Z; Courtoy PJ; Boonstra J; Toth J
    Pathol Res Pract; 1988 Dec; 184(1):116-27. PubMed ID: 2852799
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?
    Musgrove EA
    Breast Cancer Res; 2004; 6(2):65-8. PubMed ID: 14979908
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK; Iglehart JD
    J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
    Schiff R; Massarweh SA; Shou J; Bharwani L; Arpino G; Rimawi M; Osborne CK
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():10-20. PubMed ID: 16273359
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk.
    Massarweh S; Schiff R
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S15-24. PubMed ID: 17259554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 6.